Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
:0H9X
0H9X Stock Chart & Stats
Day’s Range― - ―
52-Week Range€32.50 - €48.28
Previous CloseN/A
Volume32.07K
Average Volume (3M)82.63K
Market Cap
€12.98B
Enterprise Value€22.21B
Total Cash (Recent Filing)€2.15B
Total Debt (Recent Filing)€7.55B
Price to Earnings (P/E)19.6
Beta1.03
Next Earnings
Feb 25, 2025EPS Estimate
0.8Next Dividend Ex-Date
May 23, 2025Dividend Yield2.7%
Share Statistics
EPS (TTM)2.25
Shares Outstanding293,413,450
10 Day Avg. Volume109,337
30 Day Avg. Volume82,633
Standard Deviation0.09
R-Squared0.23
Alpha-0.00402
Financial Highlights & Ratios
PEG Ratio0.42
Price to Book (P/B)N/A
Price to Sales (P/S)0.72
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€44.83Price Target Upside-0.47% Downside
Rating ConsensusHold
Number of Analyst Covering14
---
Bulls Say, Bears Say
Bulls Say
Cost ManagementFME25 savings are running ahead of plan, expecting €205m for the full year, which supports sequential margin improvement.
Financial PerformanceFresenius Medical Care beat expectations on sales and EBIT, driven by positive price and volume in Care Enablement and stable US treatment volumes.
Bears Say
Market ChallengesThere is continued caution on the dialysis market, which is seen as structurally challenged and at risk of reimbursement changes.
---
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
19.59% Mutual Funds
<0.01% Other Institutional Investors
73.74% Public Companies and
Individual Investors
0H9X FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest share price was €32.50 and its highest was €48.28 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Fresenius Medical Care AG & Co. KGaA’s market cap is €12.98B.
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is Feb 25, 2025 which is 4 days ago.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Feb 25, 2025. The company reported €0.91 earnings per share for the quarter, beating the consensus estimate of €0.799 by €0.111.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Overvalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA pays a Annually dividend of €1.19 which represents an annual dividend yield of 2.7%. See more information on Fresenius Medical Care AG & Co. KGaA dividends here
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is 0.8.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €0.91 in its last earnings report, beating expectations of €0.799. Following the earnings report the stock price went up 1.263%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in GB:0H9X
---
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€44.83 (-0.47% Downside)
€44.83 (-0.47% Downside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
30.16%
12-Months-Change
Fundamentals
Return on Equity
3.82%
Trailing 12-Months
Asset Growth
-1.07%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
---
0H9X Stock 12 Month Forecast
Average Price Target
€44.83
▼(-0.47% Downside)
Technical Analysis
Best Analysts Covering 0H9X
1 Year
1 Year Success Rate
14/20 ratings generated profit
1 Year Average Return
+12.14%
reiterated a buy rating last month
Copying Victoria Lambert's trades and holding each position for 1 Year would result in 70.00% of your transactions generating a profit, with an average return of +12.14% per trade.
---